[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340008-105":59,"doc-detail-340008-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-application-of-bacteria-nanomaterial-hybrids-in-antitumor-therapy","The application of bacteria-nanomaterial hybrids in antitumor therapy","","Adverse effects and multidrug resistance remain significant obstacles in conventional cancer therapy. Nanomedicines offer potential to reduce side effects through nanoscale dimensions and tunable surface characteristics, yet persistent issues include low targeting efficiency and poor tumor penetration. Anaerobic bacteria show high selectivity for primary tumors and metastatic cancers, with superior penetration and safety. This review analyzes bacterial tumor-targeting mechanisms and summarizes synthesis strategies for bacteria-nanomaterial hybrids, highlighting their applications alongside chemotherapy, radiotherapy, and photothermal/photodynamic therapy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-application-of-bacteria-nanomaterial-hybrids-in-antitumor-therapy/340008/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-application-of-bacteria-nanomaterial-hybrids-in-antitumor-therapy/340008.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are conventional cancer therapies still limited by adverse effects and resistance?","Question",{"text":113,"@type":114},"Conventional chemotherapy often lacks tumor-specific targeting, resulting in insufficient drug concentrations at tumor sites. Systemic distribution leads to toxicity and adverse effects such as myelosuppression, mucositis, and organ dysfunction, while multidrug resistance further reduces effectiveness.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What advantages do nanomedicines provide, and what challenges remain?",{"text":118,"@type":114},"Nanomedicines can improve drug half-life, stability, bioavailability, and tumor accumulation through nanoscale design features like tunable surfaces and controlled release. However, nanoparticle tumor targeting is hindered by tumor microenvironment barriers such as dense stroma, heterogeneous vascular leakage, and hypoxia.",{"name":120,"@type":111,"acceptedAnswer":121},"How do anaerobic bacteria contribute to anticancer treatment when combined with nanomaterials?",{"text":122,"@type":114},"Anaerobic bacteria exhibit high selectivity for primary tumors and metastatic cancers and can achieve superior tumor penetration with good safety. Combining them with nanomaterials aims to complement each approach’s limitations, enabling targeted delivery and supporting chemotherapy, radiotherapy, and photothermal/photodynamic therapy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340008,1790800349,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Xiao et al. Journal of Nanobiotechnology (2024) 22:536  \n[https://doi.org/10.1186/s12951-024-02793-x](https://doi.org/10.1186/s12951-024-02793-x)  \nJournal of Nanobiotechnology  \nREVIEW Open Access  \nThe application of bacteria-nanomaterial hybrids in antitumor therapy  \nSusu Xiao 1†, Min Mu 1†, Chenqian Feng 1, Shulin Pan 1 and Nianyong Chen 1*  \nAbstract  \nAdverse effects and multidrug resistance remain significant obstacles in conventional cancer therapy. Nanomedicines, with their intrinsic properties such as nano-sized dimensions and tunable surface characteristics, have the potential to mitigate the side effects of traditional cancer treatments. While nanomaterials have been widely applied in cancer treatment, challenges such as low targeting efficiency and poor tumor penetration persist. Recent research has shown that anaerobic bacteria exhibit high selectivity for primary tumors and metastatic cancers, offering good safety and superior tumor penetration capabilities. This suggests that combining nanomaterials with bacteria could complement their respective limitations, opening vast potential applications in cancer therapy. The use of bacteria in combination with nanomaterials for anticancer treatments, including chemotherapy, radiotherapy, and photothermal/photodynamic therapy, has contributed to the rapid development of the field of bacterial oncology treatments. This review explores the mechanisms of bacterial tumor targeting and summarizes strategies for synthesizing bacterial-nanomaterial and their application in cancer therapy. The combination of bacterial-nanomaterial hybrids with modern therapeutic approaches represents a promising avenue for future cancer treatment research, with the potential to improve treatment outcomes for cancer patients. Keywords Bacteria, Nanomaterials, Antitumor therapy, Tumor targeting, Hypoxia  \nIntroduction  \nCancer remains a leading cause of death globally, posing a significant threat to human health [1]. The development of effective cancer treatments is hampered by the complexity and heterogeneity of tumor biology [2–4]. While traditional chemotherapy has played a crucial role in prolonging patient survival, its lack of tumorspecific targeting often leads to suboptimal drug concentrations at the tumor site, diminishing therapeutic efficacy [5–7]. Furthermore, the systemic distribution of  \n†Susu Xiao and Min Mu contributed equally to this work.  \n*Correspondence: Nianyong Chen [n_ychen@hotmail.com](n_ychen@hotmail.com)  \nFull list of author information is available at the end of the article  \nmost chemotherapy drugs results in toxicity and various adverse effects, including myelosuppression, mucositis, and organ dysfunction [8–11]. These limitations highlight the urgent need for targeted drug delivery methods in cancer therapy. [12]. Current research in cancer therapeutics focuses on enhancing the targeting specificity and delivery efficiency of anticancer agents while simultaneously minimizing adverse effects. The development of nanotechnology over the past few decades has led to the emergence of numerous promising biomedical materials. Nanomaterials have been extensively explored for improving cancer diagnosis and treatment due to their unique physicochemical properties, including nano-scale size, tunable surface characteristics, and capabilities for encapsulation and controlled drug release [2, 13]. This has significantly advanced cancer therapy research. Compared to traditional chemotherapy drugs, nanomedicines  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this li","cbCaijXmMmIA4b1x","https://ap.wps.com/l/cbCaijXmMmIA4b1x","pdf",3401168,24,"English","# Introduction\n## Challenges in conventional cancer therapy\n## Promise and limitations of nanomedicines\n## Bacteria-based targeting and the rationale for hybrid systems\n# Review scope and structure\n## Mechanisms of bacterial tumor targeting\n## Strategies for synthesizing bacterial-nanomaterial hybrids\n## Applications in anticancer therapy","[{\"question\":\"Why are conventional cancer therapies still limited by adverse effects and resistance?\",\"answer\":\"Conventional chemotherapy often lacks tumor-specific targeting, resulting in insufficient drug concentrations at tumor sites. Systemic distribution leads to toxicity and adverse effects such as myelosuppression, mucositis, and organ dysfunction, while multidrug resistance further reduces effectiveness.\"},{\"question\":\"What advantages do nanomedicines provide, and what challenges remain?\",\"answer\":\"Nanomedicines can improve drug half-life, stability, bioavailability, and tumor accumulation through nanoscale design features like tunable surfaces and controlled release. However, nanoparticle tumor targeting is hindered by tumor microenvironment barriers such as dense stroma, heterogeneous vascular leakage, and hypoxia.\"},{\"question\":\"How do anaerobic bacteria contribute to anticancer treatment when combined with nanomaterials?\",\"answer\":\"Anaerobic bacteria exhibit high selectivity for primary tumors and metastatic cancers and can achieve superior tumor penetration with good safety. Combining them with nanomaterials aims to complement each approach’s limitations, enabling targeted delivery and supporting chemotherapy, radiotherapy, and photothermal/photodynamic therapy.\"}]","The application of bacteria-nanomaterial hybrids in antitumor therapy | PDF",1790033679,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02c315e554a4f252b6255f64d198832d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bcfdbd0f29f85143514c226a1f06655d.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca40b89465d89616b89fcb0f1c4e6c76.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ac5697e860657bca59a32f1605ad179.webp",980,1306]